{"archive_url":"http://www.ebi.ac.uk/ena/data/view/ERX298127","experiment":{"EXPERIMENT_TYPE":"mRNA-seq","EXPERIMENT_ID":"ERX298127","attributes":{"EXPERIMENT_TYPE":["mRNA-seq"],"LIBRARY_GENERATION_FRAGMENTATION":["rRNA depleted RNA was fragmented using 5xfragmentation buffer(200mM Tris Acetate, 500 mM Potassium Acetate, 150 mM Magnesium Acetate, pH8.2);buffer and NF-H20 were added to RNA to make RNA solution in 1x buffer,  incubated for 1.5 minutes at 95?C; reaction was stopped on ice for 10 minutes."],"LIBRARY_GENERATION_PCR_POLYMERASE_TYPE":["Kapa High-Fidelity DNA Polymerase (Kapa Biosystems)"],"LIBRARY_GENERATION_PCR_F_PRIMER_SEQUENCE":["AATGATACGGCGACCACCGAGATCTACAC"],"PREPARATION_INITIAL_RNA_QNTY":["500ng"],"LIBRARY_GENERATION_PCR_THERMOCYCLING_PROGRAM":["30\" 98?C, [40\" 98?C, 30\" 65?C, 30\" 72?C]10 cycles,  5' 72?C, hold 4?C"],"AMPLIFIED":["TRUE"],"LIBRARY_GENERATION_PCR_TEMPLATE_CONC":["NA"],"LIBRARY_GENERATION_PCR_PRIMER_CONC":["25?M"],"LIBRARY_GENERATION_PCR_R_PRIMER_SEQUENCE":["CAAGCAGAAGACGGCATACGAGAT"],"LIBRARY_GENERATION_PCR_PRODUCT_ISOLATION_PROTOCOL":["PCR Purification Kit using  MinElute  column (Qiagen)"],"LIBRARY_GENERATION_PROTOCOL":["upto 30 mg cDNA was end repaired and a 3' A overhang was created using Klenow exo (3? to 5? exo minus) ( (New England Biolabs)) for 30 minutes at 37?C. The cDNA was purified using the MinElute Reaction Cleanup Kit (Qiagen)according to manufacturers recommendations. Nexflex adapter (BiooScientific, TX, USA) was ligated to the cDNA at room temperature for 15 minutes with T4 DNA ligase (Promega). Adapter-ligated cDNA was purified using the Minelute Reaction Cleanup Kit(Qiagen). Size selection was performed using the 2% E-Gel SizeSelect Agarose Gels and a 100 bp DNA marker according to manufacturers recommendations.  Adapter-ligated DNA molecules were enriched by PCR with reaction composition: 23 ?l DNA,  2 ?l PE PCR primer mix 25 ml Kapa HiFi polymerase (Ready Mix)"],"LIBRARY_GENERATION_PCR_NUMBER_CYCLES":["10"],"EXTRACTION_PROTOCOL":["RNA was extracted using Trizol reagent(Invitrogen) and purified with RNeasy Mini kit(Qiagen)."],"LIBRARY_GENERATION_3'ADAPTER_SEQUENCE":["NA"],"TEMPLATE_TYPE":["cDNA"],"PREPARATION_REVERSE_TRANSCRIPTION_PROTOCOL":["Ribo-Zero Gold RNA method, with directional RNA prep for Illumina Sequencing"],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["290-350"],"LIBRARY_GENERATION_5'ADAPTER_SEQUENCE":["NA"]},"ASSAY_TYPE":"RNA-Seq"},"archive":"ENA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS","files":[{"FORMAT":"BED","SIZE":"41M","NAME":"U-266_r01.contigs.star_grape2_crg.GRCh38.20160531.bed","FILE_TYPE":"RNA_CONTIGS_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Contigs","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.contigs.star_grape2_crg.GRCh38.20160531.bed","PROTOCOL_DOC":"rna_seq_grch38","MD5":"5b069355277492e84e87f55ed5e727f7"},{"FORMAT":"Text","SIZE":"9.7M","NAME":"U-266_r01.gene_quantification.rsem_grape2_crg.GRCh38.20160531.results","FILE_TYPE":"RNA_GENE_QUANT_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription quantification (Genes)","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.gene_quantification.rsem_grape2_crg.GRCh38.20160531.results","REACTOME_PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.gene_quantification.rsem_grape2_crg.GRCh38.20160531.reactome","PROTOCOL_DOC":"rna_seq_grch38","MD5":"9111b0f580d605d43569093e38a50e6b"},{"FORMAT":"GFF","SIZE":"1.3M","NAME":"U-266_r01.ipsa_junctions.ipsa_grape2_crg.GRCh38.20160531.gff","FILE_TYPE":"RNA_COSI_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription quantification (COSI)","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.ipsa_junctions.ipsa_grape2_crg.GRCh38.20160531.gff","PROTOCOL_DOC":"rna_seq_grch38","MD5":"9d41c65ff5cc7c0702f6406f74e7d7f0"},{"FORMAT":"bigWig","SIZE":"18M","NAME":"U-266_r01.minusStrand.star_grape2_crg.GRCh38.20160531.bw","FILE_TYPE":"RNA_SIGNAL_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.minusStrand.star_grape2_crg.GRCh38.20160531.bw","PROTOCOL_DOC":"rna_seq_grch38","MD5":"a3546d3a40ce4bad961287e7efeb73a8"},{"FORMAT":"bigWig","SIZE":"26M","NAME":"U-266_r01.minusStrandMulti.star_grape2_crg.GRCh38.20160531.bw","FILE_TYPE":"RNA_SIGNAL_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.minusStrandMulti.star_grape2_crg.GRCh38.20160531.bw","PROTOCOL_DOC":"rna_seq_grch38","MD5":"8ad041acd3bc557691436151c3556349"},{"FORMAT":"bigWig","SIZE":"18M","NAME":"U-266_r01.plusStrand.star_grape2_crg.GRCh38.20160531.bw","FILE_TYPE":"RNA_SIGNAL_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.plusStrand.star_grape2_crg.GRCh38.20160531.bw","PROTOCOL_DOC":"rna_seq_grch38","MD5":"37f1e7b08e0d886bcb97dbf054c52a43"},{"FORMAT":"bigWig","SIZE":"26M","NAME":"U-266_r01.plusStrandMulti.star_grape2_crg.GRCh38.20160531.bw","FILE_TYPE":"RNA_SIGNAL_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.plusStrandMulti.star_grape2_crg.GRCh38.20160531.bw","PROTOCOL_DOC":"rna_seq_grch38","MD5":"ed733d8127675065b8dc141621976fd2"},{"FORMAT":"GFF","SIZE":"1.5M","NAME":"U-266_r01.splicing_ratios.ipsa_grape2_crg.GRCh38.20160531.gff","FILE_TYPE":"RNA_COSI_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription quantification (COSI)","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.splicing_ratios.ipsa_grape2_crg.GRCh38.20160531.gff","PROTOCOL_DOC":"rna_seq_grch38","MD5":"33419936dbdee6cb73bc73d351cb61fb"},{"FORMAT":"Text","SIZE":"26M","NAME":"U-266_r01.transcript_quantification.rsem_grape2_crg.GRCh38.20160531.results","FILE_TYPE":"RNA_TRANSCRIPT_QUANT_STAR_CRG","ANALYSIS_GROUP":"CRG","TYPE":"Transcription quantification (Transcripts)","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/Cell_Line/U-266/Multiple_Myeloma/RNA-Seq/NCMLS/U-266_r01.transcript_quantification.rsem_grape2_crg.GRCh38.20160531.results","PROTOCOL_DOC":"rna_seq_grch38","MD5":"acd525d7467146fb7c9b8c1e56f21f18"}],"sample":{"SAMPLE_SOURCE":"Cell Line","SAMPLE_NAME":"U-266","sample_barcode":"U-266_r01","attributes":{"DIFFERENTIATION_METHOD":["Drexler HG chapter 16 Establishment and culture of leukemia-lymphoma cell in Cancer Cell Culture Methods and Protocols 2nd Edition Springer Berlin pp 181 to 200 in 2011"],"MOLECULE":["total RNA"],"DISEASE":["Multiple Myeloma"],"BATCH":["NA"],"LINEAGE":["NA"],"BIOMATERIAL_PROVIDER":["DSMZ"],"BIOMATERIAL_TYPE":["Cell Line"],"DISEASE_ONTOLOGY_URI":[{"url":"4","label":"C0026764"}],"SAMPLE_ONTOLOGY_URI":[{"url":"7","label":"CLO_0009457"}],"SEX":["Male"],"PASSAGE":["NA"],"DIFFERENTIATION_STAGE":["Plasma cell"],"LINE":["U-266"],"MEDIUM":["RPMI 1640 + 20%FBS + 1% Glutamine"]},"SAMPLE_ID":"ERS333912","SAMPLE_DESCRIPTION":"Multiple Myeloma"}}